Upright Radiotherapy Treatments Are One Step Closer to Being a Reality at McLaren Proton Therapy Center

February 07, 2024 07:28 PM GMT | By EIN Presswire
 Upright Radiotherapy Treatments Are One Step Closer to Being a Reality at McLaren Proton Therapy Center
Image source: EIN Presswire

Leo Cancer Care has delivered the second integral piece of its technology to the McLaren Proton Therapy Center in Flint, Michigan. MIDDLETON, WISCONSIN, UNITED KINGDOM, February 7, 2024 /EINPresswire.com/ -- In December 2023 a CT scanner to pair with their first upright radiotherapy solution was delivered for installation in their testing and development environment. It will allow the center to continue its integration and testing activities. This exciting delivery means the McLaren Proton Therapy Center is one step closer to making history and treating the first patient with this pioneering technology.

In June 2022, the McLaren Proton Therapy Center established a partnership with Leo Cancer Care, a company headquartered in Wisconsin that specializes in developing innovative radiation therapy solutions. This collaboration marks an important milestone as Leo Cancer Care pioneers a novel approach, allowing patients to receive their treatments in a seated, upright position.

The innovative solution is named Marie™ after the renowned physicist Marie Curie who was awarded the Nobel Prize twice. It is based on research that shows upright positioning reduces organ movement and improves treatment accuracy (Mackie et al 2021). Additionally, Marie™ will enhance patient experiences by enabling direct eye contact and improved interaction between patients and clinicians during treatment.

The McLaren Proton Therapy Center is making exciting progress as it nears the completion of two new rooms that will house the cutting-edge Marie™ systems. The center received the first component of the advanced Marie™ solution, the upright patient positioning system, back in July 2023. This system has already been successfully installed in their testing facility, allowing for seamless integration and testing during the ongoing construction period.

“McLaren is installing these two gantry-less Marie™ solutions from Leo Cancer Care into a space originally planned to house a single rotating gantry system,” said Vahagn Nazaryan, PhD, executive director of the center. “This decision will significantly increase McLaren's capacity to treat patients, increasing accessibility to life-saving and life-extending proton therapy.”

*Please note that Leo Cancer Care is seeking 510k approval for its technology prior to first patient treatment.

Reference: Thomas Rockwell Mackie, Stephen Towe, Niek Schreuder; Is upright radiotherapy medically and financially better? AIP Conference Proceedings 30 April 2021; 2348 (1): 020002. https://doi.org/10.1063/5.0051770

Sophie Towe
Leo Cancer Care
+44 7487 557593
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next